Articles from: als-advocacy.blogspot.com
Mashup Score:2
als-advocacy.blogspot.comDear FDA Advisory Committee - 2 months
Mashup Score:2
Below are my comments submitted to the FDA Advisory Committee that will be meeting to address questions related to the Amylyx AMX0035...
-
We're not looking for miracles. We're looking for a little more time. We're looking for a few more buttons, https://t.co/7HIlK5TdD7 - view on twitter
Mashup Score:2
als-advocacy.blogspot.comDear FDA Advisory Committee - 2 months
Mashup Score:2
Below are my comments submitted to the FDA Advisory Committee that will be meeting to address questions related to the Amylyx AMX0035...
-
Dear FDA Advisory Committee, https://t.co/7HIlK5TdD7 https://t.co/7HIlK5TdD7 - view on twitter
Mashup Score:1
als-advocacy.blogspot.comDear FDA Advisory Committee - 2 months
Mashup Score:1
Below are my comments submitted to the FDA Advisory Committee that will be meeting to address questions related to the Amylyx AMX0035...
-
Dear FDA Advisory Committee https://t.co/7HIlK5TdD7 https://t.co/7HIlK5TdD7 - view on twitter
Mashup Score:2
als-advocacy.blogspot.comMislead or Lead - 3 months
Mashup Score:2
Dear. CDC and ATSDR, You can lead or you can choose to continue to mislead. The choice is yours. ALS Prevalence and Incidence...
-
I sincerely hope this didn't include another $10,000,000 autopay for CDC ATSDR ALS Registry. Enough is enough. https://t.co/HEzozC2cIn https://t.co/HEzozC2cIn - view on twitter
Mashup Score:2
als-advocacy.blogspot.comMislead or Lead - 3 months
Mashup Score:2
Dear. CDC and ATSDR, You can lead or you can choose to continue to mislead. The choice is yours. ALS Prevalence and Incidence...
-
The path they have chosen... https://t.co/HEzozC2cIn https://t.co/HEzozC2cIn - view on twitter
Mislead or Lead - 3 months
Dear. CDC and ATSDR, You can lead or you can choose to continue to mislead. The choice is yours. ALS Prevalence and Incidence...
-
Mislead or Lead https://t.co/HEzozC2cIn https://t.co/HEzozC2cIn - view on twitter
“The Patient Is At The Center Of Everything We Do” But are you really patient-centric? The process was clever enough. ALS Clinic...
-
Sometimes "patient-centric" just leaves people with ALS in the middle of a roundabout... https://t.co/MvmsuhAVK6 - view on twitter
Mashup Score:1
als-advocacy.blogspot.comThis Is What I Had To Say At The FDA Today - 3 months
Mashup Score:1
Thank you for the opportunity to speak directly to the FDA today. To have so many different stakeholders in the room together hearing...
-
9 years ago. https://t.co/NBP82D4dVF We should reconvene those who were there. So many have died that the room would be pretty empty except for us healthies who have not caused meaningful change. Ugh. - view on twitter
Mashup Score:11
als-advocacy.blogspot.comThis Was Simply Wrong On So Many Levels — Neuraltus NP001 - 4 months
Mashup Score:11
This is the story of a couple of my friends and an investigational drug for ALS — Neuraltus’ NP001. It contains many pieces of...
-
The evil nature of ALS leaves us with a poor sense of history. Some can fade away and reinvent themselves a few years later. We must not forget things like this. https://t.co/NjnTXh065b - view on twitter
From a press release hot off the presses… FISHER TO CARRY THE COLORS OF “CAREY’S HOPE” AT CHICAGO AND KENTUCKY by Sarah Fisher on...
.@sarahfisher has been a good friend to the ALS cause with good reason. Looking forward to her pacing the field, @IMS https://t.co/cifJeD3pA5 https://t.co/cifJeD3pA5 - view on twitter